Article Details

Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Rating of "Buy" from Brokerages

Retrieved on: 2020-12-02 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

Denali Therapeutics Inc. (NASDAQ:DNLI) Receives Average Rating of "Buy" from Brokerages. View article details on hiswai:

Excerpt

<b>Vanguard Group</b> Inc. now owns 7,085,930 shares of the company's stock worth $171,337,000 after buying an additional 177,599 shares during the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo